The Culturing or farming of aquatic animals like fishes, crustaceans, mollusks, algae, aquatic plants, and the other aquatic organisms in different types of water is termed as “Aquaculture”. The cultivation process involves nurturing of these aquatic organisms in the controlled condition either in fresh or salt water. Thereafter, these aquatic organisms are harvested to be served as the source of nutrition or many other purposes. The aquatic animals are very sensitive and prone to various epidemic diseases. The other factors affecting the aquatic cultured animals are pathogens (e.g. viruses, bacteria, fungi and parasites); which exist in all natural water bodies.
At the same time, crowded culture environment poses high risk for infection. Crowding also results in fish knocking; eventually leading to surface wounds which is a cause for inaction. These can be cured using several FDA approved antibiotics and the other medicines. Apart from diseases, medicines are used to improve the wellbeing of the fish in the aquaculture.
The list of drugs includes chorionic gonadotropin, florfenicol, formalin solution, hydrogen peroxide, oxytetracycline, tricaine methane sulfonate, acetic acid, calcium chloride, sulfadimethoxine/ormetoprim combination, fuller’s earth, garlic (whole form), ice, magnesium sulfate, papain, calcium oxide, carbon dioxide gas, potassium chloride, povidone iodine, sodium sulfite, thiamine hydrochloride, sodium bicarbonate, sodium chloride, urea and tannic acid.
These drugs take care of the aquatic animals fighting with several diseases which are not only harmful to the aquatic animals but also to the consumer. There are two different categories of diseases which affect the aquatic population namely diseases due to pathogens which are indigenous to the local environment and exotic pathogens.
A lot of advancements are taking place in the aquaculture therapeutics as there are several diseases affecting the animals cultured in the aquaculture. There are several diseases driving the aquaculture therapeutics market. Mostly these diseases are dependent on hygiene conditions that are to be maintained. Advances in aquaculture therapeutics and growing demand for the more effective aquaculture therapeutic drugs are the factors expected to drive the growth of aquaculture therapeutics market. Also, the demand for aquaculture is rapidly growing day by day due to the decreasing number of the oceanic fish and increasing consumption of the fishes at a global level.
The global aquaculture therapeutics market has been segmented on the basis of product type, end–user, and geography. On the basis of Product Type, the global aquaculture therapeutics market is divided into Chorionic Gonadotropin, Formalin Solution, Florfenicol, Oxytetracycline, Tricaine Methane Sulfonate, Hydrogen Peroxide, and Sulfadimethoxine/Ormetoprim combination.
On the basis of end-user, the global aquaculture therapeutics market is divided into veterinary pharmacies, veterinary hospitals, e-Commerce, and veterinary clinics. On the basis of Environment, the global aquaculture therapeutics market is divided into fresh water, marine water, and brackish water. The fresh water environment dominates the aquaculture market and is anticipated to occupy more than 61% of the overall market share by 2025. The aquaculture in fresh water is growing primarily because of the decrease of fish population in oceans and rivers.
The fresh water culture environment includes ponds, tanks, and cages in fresh water. Aquaculture species such as carp, tilapia, and trout are commonly cultured in this environment. Over three-fourth of the production in this environment is of carp and the other cyprinids using semi-intensive methods. Low-income and food-deficit countries contribute for the largest fresh water aquaculture production.
On the basis of Geography, the global aquaculture therapeutics market is divided into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. The key players of global aquaculture therapeutics market are TunaTech GmbH, ViAqua Therapeutics Ltd, Alpharma Inc., Blue Ridge Aquaculture, Cermaq ASA, Cooke Aquaculture, Nireus Aquaculture S.A and Tassal group Ltd., Nireus S.A., Unima Group, Nutreco Holding N.V., Kona Bay Marine Resources, Royal Greenland, Sea Watch International Ltd., Selonda Aquaculture S.A., StarKist Taylor Shellfish Inc., TriMarine International and Seafood Company.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is better than the other. The report will account for Covid19 as a key market contributor.